It's a hard market for camera right now, and after both Canon and Nikon both had revisions to their forecasts, Olympus have also followed by cutting their full-year sales and profit forecast.
Olmypus have said that they expect sales to tip at around $7.8 billion, down from their first forecast of $8.09 billion. Profits will drop by 25%, too. When most people think Olympus, they think cameras, but Olympus aren't all just about cameras - they have pushed into the medical equipment and endoscope markets, too.
Last year saw Sony buy a $642 million stake in Olympus which was mainly for the medical imaging side of things. Over the past two years, Olympus' main goals have been to focus on their Pen and OM-D interchangeable lends (ILC) cameras, which has caused people to think the company were slowly dragging themselves out of the traditional SLR market.
On top of this, the last time Olympus released a major product in their E-series of SLRs was in 2010 with their professional-grade E-5. During an interview with DPReview, CEO and President Hiroyuki denied claims that Olympus were pulling out of the SLR market, where he said that both ILCs and SLRs are important in strengthening the future of Olympus' cameras.